BY MARY PAQUETTE, RN, BSN, CCM, AND MELINDA BAXTER, RN, MSN, CCM
Gene therapy is the latest high-cost challenge facing health plans and reinsurers alike. The need to understand issues associated with treatments, medical management, network management and contracting will evolve and persist.